blood transfusion, autologous
Showing 1 - 25 of >10,000
Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss Trial in Edmonton (Autologous Whole Blood Management,
Not yet recruiting
- Postoperative Hemorrhage
- +2 more
- Autologous Whole Blood Management
- Standard Care involving allogenic and/or derivative transfusion.
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 25, 2023
Cervical Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Cervical Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 13, 2022
Arthroplasty, Replacement, Knee, Blood Transfusion, Autologous, Blood Transfusion Trial in Szczecin (Bellovac ABT, Allogenic
Completed
- Arthroplasty, Replacement, Knee
- +2 more
- Bellovac ABT
- Allogenic Blood Transfusion
-
Szczecin, PolandSpecjalistyczny Szpital Im. Alfreda Sokolowskiego
Nov 10, 2021
Cardiac Disease, Bleeding Postoperative Trial in Aurora (Fresh Autologous whole Blood, Standard of Care Expectant management of
Recruiting
- Cardiac Disease
- Bleeding Postoperative
- Fresh Autologous whole Blood
- Standard of Care Expectant management of bleeding
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 28, 2022
Ovarian Cancer Trial in Chongqing (Autologous blood transfusion with haematopoietic stem cells)
Recruiting
- Ovarian Cancer
- Autologous blood transfusion with haematopoietic stem cells
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
May 29, 2022
The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers Trial in Paris
Not yet recruiting
- The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers
- Autologous Blood Transfusion
- No transfusion
-
Paris, IDF, FranceEtablissement Français du Sang IDF, Hôpital de la Pitié Salpêtri
Nov 19, 2021
Autologous Blood Transfusion Trial in Taizhou (modified blood collection method)
Completed
- Autologous Blood Transfusion
- modified blood collection method
-
Taizhou, Zhejiang, ChinaTaizhou Hospital of Zhejiang Province affiliated to Wenzhou Medi
Sep 12, 2022
Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)
Recruiting
- Transfusion Dependent Beta Thalassemia
- +3 more
- EDIT-301
-
Oakland, California
- +3 more
Jan 3, 2023
Transfusion Related Complication Trial in Cleveland (SNO, Normal Saline, Red Blood Cell)
Recruiting
- Transfusion Related Complication
- SNO
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Dec 9, 2021
Type 1 Diabetes Trial in Gainesville (Autologous Umbilical Cord Blood Transfusion, Cord blood)
Completed
- Type 1 Diabetes Mellitus
- Autologous Umbilical Cord Blood Transfusion
- Cord blood
-
Gainesville, FloridaUniversity of Florida
Feb 3, 2022
Transfusion Dependent Beta-Thalassaemia Trial in Guangzhou, Shenzhen, Tianjin (ET-01)
Active, not recruiting
- Transfusion Dependent Beta-Thalassaemia
- ET-01
-
Guangzhou, Guangdong, China
- +3 more
May 9, 2022
Transfusion Dependent Beta-thalassemia Trial in United States (ST-400 Investigational product)
Active, not recruiting
- Transfusion Dependent Beta-thalassemia
- ST-400 Investigational product
-
Los Angeles, California
- +5 more
Jul 6, 2022
Beta-Thalassemia, Thalassemia, Genetic Diseases, Inborn Trial in Worldwide (CTX001)
Active, not recruiting
- Beta-Thalassemia
- +4 more
- CTX001
-
Stanford, California
- +11 more
Nov 30, 2022
Placenta Accreta Spectrum Trial in Foshan (Ringer's Lactated)
Recruiting
- Placenta Accreta Spectrum
- Ringer's Lactated
-
Foshan, Guangdong, ChinaMaternal and Child Health Hospital of Foshan
Jun 15, 2021
Spinal Surgery Trial in Glostrup (Sangvia)
Completed
- Spinal Surgery
- Sangvia
-
Glostrup, DenmarkClinical Trial Unit, Glostrup Hospital, University of Copenhagen
Nov 10, 2021
Safety Issues;Effect of Drugs Trial in Guangzhou (0.9% Sodium Chloride, Autologous Umbilical Cord Blood)
Recruiting
- Safety Issues;Effect of Drugs
- 0.9% Sodium Chloride
- Autologous Umbilical Cord Blood
-
Guangzhou, Guangdong, ChinaGuangdong Women and Children's Hospital and Health Institute
Feb 21, 2021
ß-thalassemia Trial (BD211)
Not yet recruiting
- β-thalassemia
- BD211
- (no location specified)
Mar 15, 2023
ß-thalassemia Trial in Shanghai (BD211)
Not yet recruiting
- β-thalassemia
- BD211
-
Shanghai, ChinaShanghai Ruijin Hospital
Mar 16, 2023
Platelet Transfusion Refractoriness Trial in Suzhou (Cryopreserved autologous platelet transfusion)
Recruiting
- Platelet Transfusion Refractoriness
- Cryopreserved autologous platelet transfusion
-
Suzhou, Jiangsu, ChinaFirst Affiliated Hospital of Soochow University
Mar 7, 2023
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
Anemia, Age Problem, Ultrasonography Trial in Nîmes (transthoracic echocardiography)
Not yet recruiting
- Anemia
- +2 more
- transthoracic echocardiography
-
Nîmes, Gard, FranceCHU de Nîmes
Sep 25, 2023
ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)
Recruiting
- β-thalassemia
- β-globin restored autologous hematopoietic stem cells
-
Shenzhen, Guangdong, ChinaShenzhen University General Hospital
May 8, 2023
Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Refractory, Non-Hodgkin's Lymphoma, Relapsed
Recruiting
- Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
- +2 more
- Autologous CAR19 T lymphocytes
-
Prague, CzechiaInstitute of Hematology and Blood Transfusion, Czech Republic
Aug 3, 2022
a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)
Recruiting
- α-thalassemia
- α-globin restored autologous hematopoietic stem cells
-
Nanning, Guangxi, ChinaPLA Joint Logistic Support Force No. 923 Hospital
May 6, 2023